| Benish Aqil, MD | |
|
130 S Bryn Mawr Ave, Suite H321, Bryn Mawr, PA 19010-3121 | |
| (484) 337-4097 | |
| (484) 337-4082 |
| Full Name | Benish Aqil |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 14 Years |
| Location | 130 S Bryn Mawr Ave, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245522481 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD452853 (Pennsylvania) | Secondary |
| 208M00000X | Hospitalist | MD452853 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
A three-year follow-up study of patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial revealed that increased mortality among patients with advanced chronic hepatitis C who received long-term peginterferon therapy was attributed to non-liver related causes and occurred primarily in patients with bridging fibrosis. No pattern to this excess mortality was evident to researchers, but deaths were unrelated to the peginterferon treatment. Full findings are published in the April issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
Camouflaging an impotent AIDS virus in new clothes enables it to hunt down metastasized melanoma cells in living mice, reports a UCLA AIDS Institute study in the Feb. 13 online edition of Nature Medicine.
Last year at the DMC Children's Hospital of Michigan, nearly 500 children were treated and admitted for burn injuries. As a result of the spectrum of quality care provided to burn patients from the pre-hospital phase through the rehabilitation process and having met rigorous standards for specific criteria set by the American Burn Association and the Committee on Trauma of the American Colleges of Surgeons, the DMC Children's Hospital of Michigan burn center is now the state's only verified pediatric burn center exclusively dedicated to the needs of children.
› Verified 7 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
A three-year follow-up study of patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial revealed that increased mortality among patients with advanced chronic hepatitis C who received long-term peginterferon therapy was attributed to non-liver related causes and occurred primarily in patients with bridging fibrosis. No pattern to this excess mortality was evident to researchers, but deaths were unrelated to the peginterferon treatment. Full findings are published in the April issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
Camouflaging an impotent AIDS virus in new clothes enables it to hunt down metastasized melanoma cells in living mice, reports a UCLA AIDS Institute study in the Feb. 13 online edition of Nature Medicine.
Last year at the DMC Children's Hospital of Michigan, nearly 500 children were treated and admitted for burn injuries. As a result of the spectrum of quality care provided to burn patients from the pre-hospital phase through the rehabilitation process and having met rigorous standards for specific criteria set by the American Burn Association and the Committee on Trauma of the American Colleges of Surgeons, the DMC Children's Hospital of Michigan burn center is now the state's only verified pediatric burn center exclusively dedicated to the needs of children.
› Verified 7 days ago
| Entity Name | Monogram Health Professional Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134739089 PECOS PAC ID: 4880004183 Enrollment ID: O20220808002650 |
News Archive
A three-year follow-up study of patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial revealed that increased mortality among patients with advanced chronic hepatitis C who received long-term peginterferon therapy was attributed to non-liver related causes and occurred primarily in patients with bridging fibrosis. No pattern to this excess mortality was evident to researchers, but deaths were unrelated to the peginterferon treatment. Full findings are published in the April issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
Camouflaging an impotent AIDS virus in new clothes enables it to hunt down metastasized melanoma cells in living mice, reports a UCLA AIDS Institute study in the Feb. 13 online edition of Nature Medicine.
Last year at the DMC Children's Hospital of Michigan, nearly 500 children were treated and admitted for burn injuries. As a result of the spectrum of quality care provided to burn patients from the pre-hospital phase through the rehabilitation process and having met rigorous standards for specific criteria set by the American Burn Association and the Committee on Trauma of the American Colleges of Surgeons, the DMC Children's Hospital of Michigan burn center is now the state's only verified pediatric burn center exclusively dedicated to the needs of children.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benish Aqil, MD 130 S Bryn Mawr Ave, Suite H321, Bryn Mawr, PA 19010-3121 Ph: (484) 337-4097 | Benish Aqil, MD 130 S Bryn Mawr Ave, Suite H321, Bryn Mawr, PA 19010-3121 Ph: (484) 337-4097 |
News Archive
A three-year follow-up study of patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial revealed that increased mortality among patients with advanced chronic hepatitis C who received long-term peginterferon therapy was attributed to non-liver related causes and occurred primarily in patients with bridging fibrosis. No pattern to this excess mortality was evident to researchers, but deaths were unrelated to the peginterferon treatment. Full findings are published in the April issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
Camouflaging an impotent AIDS virus in new clothes enables it to hunt down metastasized melanoma cells in living mice, reports a UCLA AIDS Institute study in the Feb. 13 online edition of Nature Medicine.
Last year at the DMC Children's Hospital of Michigan, nearly 500 children were treated and admitted for burn injuries. As a result of the spectrum of quality care provided to burn patients from the pre-hospital phase through the rehabilitation process and having met rigorous standards for specific criteria set by the American Burn Association and the Committee on Trauma of the American Colleges of Surgeons, the DMC Children's Hospital of Michigan burn center is now the state's only verified pediatric burn center exclusively dedicated to the needs of children.
› Verified 7 days ago
Dr. Lawrence K Mcknight, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Suite H-321, Bryn Mawr, PA 19010 Phone: 610-526-4097 Fax: 610-526-4082 | |
Courtney Ellen Nelson, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 610-526-3000 | |
Dr. Karthik Gournani, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 130 S Bryn Mawr Ave, H Wing, Suite 321, Bryn Mawr, PA 19010 Phone: 484-337-4097 Fax: 484-337-4082 | |
Dr. Green Chorok Chung, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 484-337-4097 | |
Dr. Maria Dicarlantonio, DO Hospitalist Medicare: Not Enrolled in Medicare Practice Location: Bryn Mawr Hospital, 130 S. Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 610-526-4261 Fax: 610-526-4420 | |
Christi L. Rosengart, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 610-526-3000 Fax: 302-651-4945 | |
Michael J Larock, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 130 S Bryn Mawr Ave Ste H321, Bryn Mawr, PA 19010 Phone: 484-337-4097 Fax: 484-337-4082 |